Biotech · Private company
iLeukon Therapeutics, Inc.
Track this companyFree. Adds iLeukon Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- ILKN421HPhase 2 · Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)ClinicalTrials.gov · fetched Nov 12, 2026
- PembrolizumabPhase 2 · Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- ILKN421H Plus Pembrolizumab in Advanced Non-Small Cell Lung CancerPHASE2 · RECRUITING · started Jun 29, 2026ClinicalTrials.gov NCT07452224 · fetched Nov 12, 2026